Adoptive Cell Transfer of Autologous Tumor Infiltrating Lymphocytes and High-Dose Interleukin 2 in Select Solid Tumors
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Locally Advanced Refractory/Recurrent Head and Neck Cancer
- Locally Advanced Refractory/Recurrent Melanoma
- Metastatic Head and Neck Cancer
- Metastatic Melanoma
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: Non-RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03991741
- Collaborators
- Immunotherapy Foundation
- Investigators
- Principal Investigator: Gregory Daniels, MD, PhD University of California, San Diego Principal Investigator: Ezra Cohen, MD University of California, San Diego
Get Well Soon